Tapewire

Nasdaq · USD

CHRW

C. H. ROBINSON WORLDWIDE, INC.

Export transactions ↓
Tapewire entity
3306
SEC CIK
0001043277
Parsed reports
748

Last 12 months

Inside the activity.

4 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202501
Jan 202601
Feb 202643
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 09, 2022 Filed Feb 11, 2022 21:18 UTC
Biesterfeld Robert C JrDirector · President and CEO
GrantCommon Stock 7,100 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-008846 · doc4.xml · nonDerivative · entry 2

Biesterfeld Robert C Jr · CIK 0001663286 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 186,518

F2 · shares: Represents Performance-based restricted stock units that vested on February 9, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F3 · balance_after: Included in this amount are 180,242 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 5,385 shares held directly by the reporting person.

F4 · balance_after: Includes 891 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 21:18 UTC
Biesterfeld Robert C JrDirector · President and CEO
GrantCommon Stock 44,760 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-008846 · doc4.xml · nonDerivative · entry 1

Biesterfeld Robert C Jr · CIK 0001663286 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,418

F1 · shares: Restricted stock units vest ratably over a 3 year period between January 1, 2022 and December 31, 2024.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 21:20 UTC
Campbell Ben GChief Legal Officer/Secretary
GrantCommon Stock 1,154 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-008853 · doc4.xml · nonDerivative · entry 2

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,721

F2 · shares: Represents Performance-based restricted stock units that vested on February 9, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F3 · balance_after: Included in this amount are 53,236 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 5,176 shares held directly by the reporting person.

F4 · balance_after: Includes 1,309 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 21:20 UTC
Campbell Ben GChief Legal Officer/Secretary
GrantCommon Stock 7,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-008853 · doc4.xml · nonDerivative · entry 1

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,567

F1 · shares: Restricted stock units vest ratably over a 3 year period between January 1, 2022 and December 31, 2024.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 21:17 UTC
Neill Michael WChief Technology Officer
GrantCommon Stock 866 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-008840 · doc4.xml · nonDerivative · entry 2

Neill Michael W · CIK 0001744906 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,917

F2 · shares: Represents Performance-based restricted stock units that vested on February 9, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F3 · balance_after: Included in this amount are 29,438 shares of Issuer common stock issuable in settlement of an equal number of deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 184 shares held directly by the reporting person.

F4 · balance_after: Includes 295 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 09, 2022 Filed Feb 11, 2022 21:17 UTC
Neill Michael WChief Technology Officer
GrantCommon Stock 6,720 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-008840 · doc4.xml · nonDerivative · entry 1

Neill Michael W · CIK 0001744906 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,051

F1 · shares: Restricted stock units vest ratably over a 3 year period between January 1, 2022 and December 31, 2024.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:11 UTC
Zechmeister Michael PaulChief Financial Officer
GrantCommon Stock 17,706 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007304 · doc4.xml · nonDerivative · entry 1

Zechmeister Michael Paul · CIK 0001653006 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,461

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Includes 123 shares acquired pursuant to the issuer's employee stock purchase plan.

F3 · balance_after: Included in this amount are 32,700 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares credited to the reporting person's NQDC Plan account, and 5,638 shares held directly by the reporting person.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:10 UTC
Pinkerton Mac SPres. of North America Trans.
GrantCommon Stock 14,218 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007302 · doc4.xml · nonDerivative · entry 1

Pinkerton Mac S · CIK 0001763184 · Pres. of North America Trans.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,309

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 36,998 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares credited to the reporting person's NQDC Plan account, and 12,401 shares held directly by the reporting person.

F3 · balance_after: Includes 910 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:11 UTC
Short Michael JohnPresident, Global Forwarding
GrantCommon Stock 16,505 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007303 · doc4.xml · nonDerivative · entry 1

Short Michael John · CIK 0001643515 · President, Global Forwarding

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,425

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 36,425 shares of Issuer common stock issuable in settlement of an equal number of deferred shares credited to the reporting person's NQDC Plan account.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:10 UTC
OBRIEN CHRISChief Commercial Officer
GrantCommon Stock 17,497 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007300 · doc4.xml · nonDerivative · entry 1

OBRIEN CHRIS · CIK 0001255475 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,362

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 70,239 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares credited to the reporting person's NQDC Plan account.

F3 · balance_after: Includes 123 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:09 UTC
Neill Michael WChief Technology Officer
GrantCommon Stock 9,999 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007299 · doc4.xml · nonDerivative · entry 1

Neill Michael W · CIK 0001744906 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,331

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 21,852 shares of Issuer common stock issuable in settlement of an equal number of deferred shares credited to the reporting person's NQDC Plan account, and 184 shares held directly by the reporting person.

F3 · balance_after: Includes 295 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:08 UTC
Kass Jordan TPresident, Managed Services
GrantCommon Stock 10,535 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007298 · doc4.xml · nonDerivative · entry 1

Kass Jordan T · CIK 0001627920 · President, Managed Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,592

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 42,380 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares credited to the reporting person's NQDC Plan account and 89 shares directly held by the reporting person.

F3 · balance_after: Includes 123 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:08 UTC
Freeman Angela K.CHRO and ESG Officer
GrantCommon Stock 16,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007297 · doc4.xml · nonDerivative · entry 1

Freeman Angela K. · CIK 0001563847 · CHRO and ESG Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,301

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 46,866 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares credited to the reporting person's NQDC Plan account.

F3 · balance_after: Includes 435 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:07 UTC
Eijsink JeroenPresident, CH Robinson Europe
GrantCommon Stock 10,551 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007296 · doc4.xml · nonDerivative · entry 1

Eijsink Jeroen · CIK 0001653797 · President, CH Robinson Europe

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,340

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: This amount reflects 19,340 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:06 UTC
Castagnetto Michael D.President of Robinson Fresh
GrantCommon Stock 7,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007294 · doc4.xml · nonDerivative · entry 1

Castagnetto Michael D. · CIK 0001797376 · President of Robinson Fresh

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,108

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 14,985 shares of Issuer common stock issuable in settlement of an equal number of deferred shares credited to the reporting person's NQDC Plan account.

F3 · balance_after: Includes 123 shares acquired pursuant to the Issuer's employee stock purchase plan..

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:05 UTC
Campbell Ben GChief Legal Officer/Secretary
GrantCommon Stock 16,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007293 · doc4.xml · nonDerivative · entry 1

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,567

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 45,082 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 5,176 shares held directly by the reporting person.

F3 · balance_after: Includes 1,309 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
February 02, 2022 Filed Feb 4, 2022 23:04 UTC
Biesterfeld Robert C JrDirector · President and CEO
GrantCommon Stock 67,353 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-007291 · doc4.xml · nonDerivative · entry 1

Biesterfeld Robert C Jr · CIK 0001663286 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,658

F1 · shares: Represents Performance-based restricted stock units that vested on February 2, 2022, have been credited to the reporting person's account in the Issuer's NQDC Plan and will be settled on a 1 for 1 basis in shares of the Issuer's common stock.

F2 · balance_after: Included in this amount are 128,382 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 5,385 shares held directly by the reporting person.

F3 · balance_after: Includes 891 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
January 04, 2022 Filed Jan 5, 2022 21:10 UTC
Campbell Ben GChief Legal Officer/Secretary
Exercise / conversionStock Option (right to buy) · Derivative 23,750 $0.00 Strike: $63.58 $0.00
Disclosure

SEC source: 0001209191-22-001642 · doc4.xml · derivative · entry 6

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,750 shares

Expires 2025-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
January 04, 2022 Filed Jan 5, 2022 21:10 UTC
Campbell Ben GChief Legal Officer/Secretary
SaleCommon Stock 23,750 $110.22 $2,617,701.25
Disclosure

SEC source: 0001209191-22-001642 · doc4.xml · nonDerivative · entry 4

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,442

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

F3 · price: Reflects the weighted average price of 23,750 shares of common stock of C.H. Robinson Worldwide, Inc. sold by the reporting person in multiple transactions on January 4, 2022 with sale prices ranging from $110.00 to $110.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4 · balance_after: Included in this amount are 28,957 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 5,176 shares held directly by the reporting person.

F5 · balance_after: Includes 1,309 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
January 04, 2022 Filed Jan 5, 2022 21:10 UTC
Campbell Ben GChief Legal Officer/Secretary
Exercise / conversionCommon Stock 23,750 $63.58 $1,510,025.00
Disclosure

SEC source: 0001209191-22-001642 · doc4.xml · nonDerivative · entry 3

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:10 UTC
Campbell Ben GChief Legal Officer/Secretary
Exercise / conversionStock Option (right to buy) · Derivative 750 $0.00 Strike: $63.58 $0.00
Disclosure

SEC source: 0001209191-22-001642 · doc4.xml · derivative · entry 5

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,750

Underlying: Common Stock · 750 shares

Expires 2025-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:10 UTC
Campbell Ben GChief Legal Officer/Secretary
SaleCommon Stock 750 $110.19 $82,646.03
Disclosure

SEC source: 0001209191-22-001642 · doc4.xml · nonDerivative · entry 2

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,442

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

F2 · price: Reflects the weighted average price of 750 shares of common stock of C.H. Robinson Worldwide, Inc. sold by the reporting person in multiple transactions on January 3, 2022 with sale prices ranging from $110.00 to $110.275 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:10 UTC
Campbell Ben GChief Legal Officer/Secretary
Exercise / conversionCommon Stock 750 $63.58 $47,685.00
Disclosure

SEC source: 0001209191-22-001642 · doc4.xml · nonDerivative · entry 1

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 16:37 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 348 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000832 · doc4.xml · derivative · entry 2

FORTUN WAYNE M · CIK 0001008785 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,663

Underlying: Common Stock · 348 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:41 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 348 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000864 · doc4.xml · derivative · entry 2

STAKE JAMES B · CIK 0001205398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,189

Underlying: Common Stock · 348 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:41 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 348 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000867 · doc4.xml · derivative · entry 1

Tolliver Paula · CIK 0001756360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,443

Underlying: Common Stock · 348 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:40 UTC
SHORT BRIANDirector
GrantPhantom Stock (Restricted Stock Units) · Derivative 649 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000860 · doc4.xml · derivative · entry 2

SHORT BRIAN · CIK 0001256634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,626

Underlying: Common Stock · 649 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: Of the 649 restricted stock units, 348 were granted at no cost to the reporting person as a quarterly installment of the annual equity-based award provided to each non-employee director, and 301 were granted at a price of $107.63 per unit in connection with the reporting person's election to defer receipt of his most recent quarterly cash retainer payment.

F2 · price: Of the 649 restricted stock units, 348 were granted at no cost to the reporting person as a quarterly installment of the annual equity-based award provided to each non-employee director, and 301 were granted at a price of $107.63 per unit in connection with the reporting person's election to defer receipt of his most recent quarterly cash retainer payment.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:39 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 348 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000851 · doc4.xml · derivative · entry 1

Kozlak Jodee A · CIK 0001352848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,645

Underlying: Common Stock · 348 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:39 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 348 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000846 · doc4.xml · derivative · entry 2

GUILFOILE MARY · CIK 0001241724 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,620

Underlying: Common Stock · 348 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:38 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 649 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000837 · doc4.xml · derivative · entry 1

Gokey Timothy C · CIK 0001296187 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,515

Underlying: Common Stock · 649 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: Of the 649 restricted stock units, 348 were granted at no cost to the reporting person as a quarterly installment of the annual equity-based award provided to each non-employee director, and 301 were granted at a price of $107.63 per unit in connection with the reporting person's election to defer receipt of his most recent quarterly cash retainer payment.

F2 · price: Of the 649 restricted stock units, 348 were granted at no cost to the reporting person as a quarterly installment of the annual equity-based award provided to each non-employee director, and 301 were granted at a price of $107.63 per unit in connection with the reporting person's election to defer receipt of his most recent quarterly cash retainer payment.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:37 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 348 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000827 · doc4.xml · derivative · entry 2

Crawford Kermit R · CIK 0001341253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,970

Underlying: Common Stock · 348 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 31, 2021 Filed Jan 4, 2022 21:35 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 348 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-000821 · doc4.xml · derivative · entry 1

Anderson Scott P · CIK 0001289294 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,904

Underlying: Common Stock · 348 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 348 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
December 17, 2021 Filed Dec 21, 2021 22:35 UTC
OBRIEN CHRISChief Commercial Officer
SaleCommon Stock 9,445 $104.29 $985,019.05
Disclosure

SEC source: 0001209191-21-070820 · doc4.xml · nonDerivative · entry 1

OBRIEN CHRIS · CIK 0001255475 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2021.

Read SEC document
December 07, 2021 Filed Dec 9, 2021 23:03 UTC
Campbell Ben GChief Legal Officer/Secretary
Exercise / conversionStock Option (right to buy) · Derivative 19,776 $0.00 Strike: $74.57 $0.00
Disclosure

SEC source: 0001209191-21-068852 · doc4.xml · derivative · entry 3

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,776 shares

Expires 2024-12-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

F4 · derivative.exercise_date: Fully vested.

Read SEC document
December 07, 2021 Filed Dec 9, 2021 23:03 UTC
Campbell Ben GChief Legal Officer/Secretary
SaleCommon Stock 19,776 $100.00 $1,977,600.00
Disclosure

SEC source: 0001209191-21-068852 · doc4.xml · nonDerivative · entry 2

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,442

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

F2 · balance_after: Included in this amount are 28,957 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares and restricted stock units credited to the reporting person's NQDC Plan account, and 5,176 shares held directly by the reporting person.

F3 · balance_after: Includes 1,309 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
December 07, 2021 Filed Dec 9, 2021 23:03 UTC
Campbell Ben GChief Legal Officer/Secretary
Exercise / conversionCommon Stock 19,776 $74.57 $1,474,696.32
Disclosure

SEC source: 0001209191-21-068852 · doc4.xml · nonDerivative · entry 1

Campbell Ben G · CIK 0001452489 · Chief Legal Officer/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,218

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2021.

Read SEC document
November 24, 2021 Filed Nov 29, 2021 21:14 UTC
Short Michael JohnPresident, Global Forwarding
Exercise / conversionStock Option (right to buy) · Derivative 16,914 $0.00 Strike: $87.15 $0.00
Disclosure

SEC source: 0001209191-21-066985 · doc4.xml · derivative · entry 3

Short Michael John · CIK 0001643515 · President, Global Forwarding

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,276

Underlying: Common Stock · 16,914 shares

Expires 2027-12-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Stock option granted December 6, 2017 vests as to 20% of the shares subject to the option on December 31 in each of the years 2018-2022.

Read SEC document
November 24, 2021 Filed Nov 29, 2021 21:14 UTC
Short Michael JohnPresident, Global Forwarding
SaleCommon Stock 16,914 $98.11 $1,659,432.54
Disclosure

SEC source: 0001209191-21-066985 · doc4.xml · nonDerivative · entry 2

Short Michael John · CIK 0001643515 · President, Global Forwarding

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,920

F1 · price: Reflects the weighted average price of 16,914 shares of common stock of C.H. Robinson Worldwide, Inc. sold by the reporting person in multiple transactions on November 24, 2021 with sale prices ranging from $98.045 to $98.23 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Included in this amount are 19,920 shares of Issuer common stock issuable in settlement of an equal number of deferred shares credited to the reporting person's NQDC Plan account.

Read SEC document
November 24, 2021 Filed Nov 29, 2021 21:14 UTC
Short Michael JohnPresident, Global Forwarding
Exercise / conversionCommon Stock 16,914 $87.15 $1,474,055.10
Disclosure

SEC source: 0001209191-21-066985 · doc4.xml · nonDerivative · entry 1

Short Michael John · CIK 0001643515 · President, Global Forwarding

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,834

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 21:06 UTC
Pinkerton Mac SPres. of North America Trans.
Exercise / conversionStock Option (right to buy) · Derivative 4,993 $0.00 Strike: $68.81 $0.00
Disclosure

SEC source: 0001209191-21-066087 · doc4.xml · derivative · entry 3

Pinkerton Mac S · CIK 0001763184 · Pres. of North America Trans.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,993 shares

Expires 2021-12-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Fully vested.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 21:06 UTC
Pinkerton Mac SPres. of North America Trans.
SaleCommon Stock 540 $93.79 $50,646.60
Disclosure

SEC source: 0001209191-21-066087 · doc4.xml · nonDerivative · entry 2

Pinkerton Mac S · CIK 0001763184 · Pres. of North America Trans.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,091

F1 · balance_after: Includes 910 shares acquired pursuant to the Issuer's employee stock purchase plan.

F2 · balance_after: Included in this amount are 22,780 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares credited to the reporting person's NQDC Plan account, and 12,401 shares held directly by the reporting person.

Read SEC document
November 18, 2021 Filed Nov 22, 2021 21:06 UTC
Pinkerton Mac SPres. of North America Trans.
Exercise / conversionCommon Stock 4,993 $68.81 $343,568.33
Disclosure

SEC source: 0001209191-21-066087 · doc4.xml · nonDerivative · entry 1

Pinkerton Mac S · CIK 0001763184 · Pres. of North America Trans.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,631

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 21:14 UTC
Castagnetto Michael D.President of Robinson Fresh
SaleCommon Stock 177 $94.97 $16,809.69
Disclosure

SEC source: 0001209191-21-065068 · doc4.xml · nonDerivative · entry 1

Castagnetto Michael D. · CIK 0001797376 · President of Robinson Fresh

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,751

F1 · balance_after: Includes 123 shares acquired pursuant to the Issuer's employee stock purchase plan.

F2 · balance_after: Included in this amount are 7,628 shares of Issuer common stock issuable in settlement of an equal number of deferred shares credited to the reporting person's NQDC Plan account.

Read SEC document
November 08, 2021 Filed Nov 10, 2021 21:27 UTC
OBRIEN CHRISChief Commercial Officer
SaleCommon Stock 9,302 $94.32 $877,364.64
Disclosure

SEC source: 0001209191-21-063854 · doc4.xml · nonDerivative · entry 4

OBRIEN CHRIS · CIK 0001255475 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 9,445

Read SEC document
October 29, 2021 Filed Nov 2, 2021 21:52 UTC
Kass Jordan TPresident, Managed Services
SaleCommon Stock 2,000 $96.44 $192,874.00
Disclosure

SEC source: 0001209191-21-062480 · doc4.xml · nonDerivative · entry 1

Kass Jordan T · CIK 0001627920 · President, Managed Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,057

F1 · price: Reflects the weighted average price of 2,000 shares of common stock of C.H. Robinson Worldwide, Inc. sold by the reporting person in multiple transactions on October 29, 2021 with sale prices ranging from $96.40 to $96.465 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2 · balance_after: Included in this amount are 31,845 shares of Issuer common stock issuable in settlement of an equal number of vested deferred shares credited to the reporting person's NQDC Plan account and 89 shares directly held by the reporting person.

F3 · balance_after: Includes 123 shares acquired pursuant to the Issuer's employee stock purchase plan.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 16:37 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 431 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-058999 · doc4.xml · derivative · entry 2

FORTUN WAYNE M · CIK 0001008785 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,315

Underlying: Common Stock · 431 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:44 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 431 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-059032 · doc4.xml · derivative · entry 1

Tolliver Paula · CIK 0001756360 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,095

Underlying: Common Stock · 431 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:43 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 431 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-059027 · doc4.xml · derivative · entry 2

STAKE JAMES B · CIK 0001205398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,841

Underlying: Common Stock · 431 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:42 UTC
SHORT BRIANDirector
GrantPhantom Stock (Restricted Stock Units) · Derivative 804 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-059025 · doc4.xml · derivative · entry 2

SHORT BRIAN · CIK 0001256634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,977

Underlying: Common Stock · 804 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: Of the 804 restricted stock units, 431 were granted at no cost to the reporting person as a quarterly installment of the annual equity-based award provided to each non-employee director, and 373 were granted at a price of $87.00 per unit in connection with the reporting person's election to defer receipt of his most recent quarterly cash retainer payment.

F2 · price: Of the 804 restricted stock units, 431 were granted at no cost to the reporting person as a quarterly installment of the annual equity-based award provided to each non-employee director, and 373 were granted at a price of $87.00 per unit in connection with the reporting person's election to defer receipt of his most recent quarterly cash retainer payment.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:41 UTC GrantPhantom Stock (Restricted Stock Units) · Derivative 431 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-059018 · doc4.xml · derivative · entry 1

Kozlak Jodee A · CIK 0001352848 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,297

Underlying: Common Stock · 431 shares

Expires not disclosed

F1 · derivative.exercise_price: Each phantom share/restricted stock unit will be paid in one share of common stock.

F2 · shares: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F2 · price: The reporting person was granted 431 restricted stock units at no cost as a quarterly installment of the annual equity-based award provided to each non-employee director.

F3 · derivative.exercise_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

F3 · derivative.expiration_date: The restricted stock units are immediately vested, and following the reporting person's termination of service as a director, become payable in shares of common stock according to the schedule previously chosen by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.